Multi-omics Analysis of Immune Determinants of STK11 in Non-Small Cell Lung Cancer

被引:0
|
作者
Alhushki, S. K. [1 ]
Al-Muhtaseb, A. [2 ]
Abushukair, H. [3 ]
Abulrous, F. [4 ]
机构
[1] Mutah Univ, Al Karak, Jordan
[2] Hashemite Univ, Zarqa, Jordan
[3] Jordan Univ Sci & Technol, Irbid, Jordan
[4] Henry Ford Hlth, Detroit, MI USA
关键词
STK11; Immunotherapy; Non-small Cell Lung Cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP03.03-02
引用
收藏
页码:S442 / S443
页数:2
相关论文
共 50 条
  • [1] Role of STK11 in ALK-positive non-small cell lung cancer
    Zhou, Wen
    Yan, Lu-Da
    Yu, Zhi-Qiong
    Li, Na
    Yang, Yong-Hua
    Wang, Meng
    Chen, Yuan-Yuan
    Mao, Meng-Xia
    Peng, Xiao-Chun
    Cai, Jun
    ONCOLOGY LETTERS, 2022, 23 (06)
  • [2] Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
    Zheng, Yang
    Tang, Lili
    Liu, Ziling
    BMC CANCER, 2021, 21 (01)
  • [3] Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
    Yang Zheng
    Lili Tang
    Ziling Liu
    BMC Cancer, 21
  • [4] Clinical immune and genomic profiling of STK11 mutant non-squamous non-small cell lung cancer
    Yau, Edwin
    Pabla, Sarabjot
    Glenn, Sean
    Papanicolau-Sengos, Antonios
    Nesline, Mary
    Dy, Grace
    Morrison, Carl
    CANCER RESEARCH, 2020, 80 (16)
  • [5] STK11 is a Potential Therapeutic and Prognostic Biomarker and Correlates with Immune Infiltrates in Non-Small Cell Lung Cancer
    Bensalim, Imane
    Boustany, Youssra
    El Faqer, Abdelmoiz
    Laraqui, Abdelilah
    Belkadi, Bouchra
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2024, 8 (03): : 358 - 370
  • [6] STK11 mutations in non-small cell lung cancer (NSCLC): descriptive analysis and prognostic significance
    Facchinetti, Francesco
    Bluthgen, Maria Virginia
    Clain, Gabrielle Tergemina
    Faivre, Laura
    Pignon, Jean-Pierre
    Planchard, David
    Soria, Jean-Charles
    Besse, Benjamin
    Lacroix, Ludovic
    CANCER RESEARCH, 2016, 76
  • [7] Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
    Sumbly, Vikram
    Landry, Ian
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [8] Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
    Wu, Rui
    Wei, Kunchen
    Huang, Xingshuai
    Zhou, Yinge
    Feng, Xiao
    Dong, Xin
    Tang, Hao
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [9] Identification of Immunotherapy Targets in STK11 Mutant Non-Squamous Non-Small Cell Lung Cancer
    Yau, E.
    Glenn, S.
    Papinicalou-Sengos, A.
    Nesline, M.
    Morrison, C.
    Dy, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S442 - S442
  • [10] STK11/LKB1 mutation in non-small cell lung cancer: Prognostic or predictive?
    Rosellini, P.
    Girodet, P. O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 50 - 51